Treatment and prognostic factors in childhood precursor T and B cell neoplasms
Lymphoblastic lymphomas account for about 30% of childhood non-Hodgkin’s lymphoma. Stage I and Stage II lymphoblastic lymphoma is a very rare entity, and most children have advanced stage disease, as evaluated by the St. Jude staging system [44.1].
KeywordsLymphoma Leukemia Doxorubicin Methotrexate Prednisone
Unable to display preview. Download preview PDF.